Trial · NCT07890870
A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.
NCT07890870, Phase 1, Not yet recruiting, iBio, Inc.
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity. Trials, record NCT07890870. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890870
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study to Evaluate a Single Dose of IBIO-610 in Participant With Obesity.
- NCT number
- NCT07890870
- Status
- Not yet recruiting
- Phases
- Phase 1
- Enrollment
- 32 participants, estimated
- Lead sponsor
- iBio, Inc.
- Conditions
- Obesity & Overweight
- Interventions
- IBIO-610, Placebo
- First posted
- 2026-10-22
- Last updated
- 2026-10-22
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Assessment of the safety and tolerability of a single dose of IBIO-610; Incidence, severity, and relationship to study treatment of TEAEs and SAEs, as determined by clinical laboratory evaluations, vital signs, physical examinations, and ECGs. | From Day 1 through Day 252 | |
| Secondary | Pharmacokinetics of a single dose of IBO-610 | Baseline up to Week 36 | Time to maximum concentration (Tmax) |
| Secondary | Pharmacokinetics of a single dose of IBIO-610 | Baseline up to Week 36 | Maximum observed serum concentration (Cmax) |
| Secondary | Pharmacokinetics of a single dose of IBIO-610 | Baseline to last measurable concentration (AUCO-last) or up to Week 36. | Area under the curve (AUC) |
| Secondary | Pharmacokinetics of a single dose of IBIO-610 | Baseline to infinity (AUCO-inf) or up to Week 36 | AUC |
| Secondary | Pharmacokinetics of a single dose of IBIO-610 | Baseline up to Week 36 | t1/2: half life |
| Secondary | Pharmacokinetics of a single dose of IBIO-610 | Baseline through Week 36 | Apparent total body clearance (CL/F) |
| Secondary | Pharmacokinetics of a single dose of IBIO-610 | Baseline up to Week 36 | Apparent volume of distribution (Vz/F) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890870
GET https://conductscience.org/api/trials/v1/NCT07890870/registered